KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Supernus Pharmaceuticals (SUPN) Shares Issued (2016 - 2025)

Historic Shares Issued for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Q3 2025 value amounting to $23.7 million.

  • Supernus Pharmaceuticals' Shares Issued rose 58575.97% to $23.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.9 million, marking a year-over-year increase of 29390.55%. This contributed to the annual value of $14.9 million for FY2024, which is 12553.71% up from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Shares Issued stood at $23.7 million for Q3 2025, which was up 58575.97% from $3.3 million recorded in Q2 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Shares Issued peaked at $23.7 million during Q3 2025, and registered a low of $524000.0 during Q3 2021.
  • Moreover, its 5-year median value for Shares Issued was $2.3 million (2022), whereas its average is $3.7 million.
  • Per our database at Business Quant, Supernus Pharmaceuticals' Shares Issued skyrocketed by 692187.5% in 2021 and then plummeted by 8853.6% in 2023.
  • Supernus Pharmaceuticals' Shares Issued (Quarter) stood at $1.6 million in 2021, then surged by 79.62% to $2.8 million in 2022, then crashed by 61.4% to $1.1 million in 2023, then skyrocketed by 529.76% to $6.9 million in 2024, then soared by 245.22% to $23.7 million in 2025.
  • Its Shares Issued was $23.7 million in Q3 2025, compared to $3.3 million in Q2 2025 and $2.0 million in Q1 2025.